Our News on Newswise

8th Joint ACTRIMS-ECTRIMS (MSVirtual2020) Meeting to Be Held Virtually September 11-13, 2020 with an Encore Event on September 26th with Late Breakers and Special Session on COVID-19

Registered media to MSVirtual2020 will have access to the full program including plenary sessions, invited speakers and platform presentations of abstracts, poster presentations, teaching courses, and industry supported satellite symposia, both...
30-Jun-2020 8:00 AM EDT Add to Favorites

Letter from ACTRIMS President on MSVirtual2020

I am pleased to announce that the 8th Joint ACTRIMS-ECTRIMS Meeting will be held from September 11-13, 2020, with a special encore featuring Late-Breaking News and a COVID-19 Session on September 26.
29-Jun-2020 11:30 AM EDT Add to Favorites

Newswise: Quintanaofficial2019.jpg

Neurology Professor from Harvard Medical School Wins Barancik Prize for Innovation in MS Research for Work Resulting in New Tools and Treatments to Combat MS

Dr. Francisco J. Quintana to receive the award and deliver the Barancik Prize lecture at the ACTRIMS Forum 2020 for work resulting in new tools and treatments to combat MS
20-Feb-2020 4:30 PM EST Add to Favorites

Newswise: A26Y0662-2.jpg

New Research Links Genetics and MS Severity, Offers Innovative Treatment Ideas to Combat MS and Other Neurodegenerative Diseases

Dr. Peter Calabresi, professor of Neurology and Neuroscience at the Johns Hopkins School of Medicine and Director of the Johns Hopkins Multiple Sclerosis (MS) Center, will present his team’s discovery of a possible link between severe damage and...
18-Feb-2020 3:25 PM EST Add to Favorites

Newswise: CALABRESI.jpg

Networks in multiple sclerosis will be the focus at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2020 Forum

Approximately 1,200 researchers and clinicians are expected to attend the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) annual Forum Feb. 27-29, 2020, in West Palm Beach, Florida.
6-Dec-2019 4:50 PM EST Add to Favorites

Newswise: Akassoglou2016_photo.jpg

University of California Scientist Wins Barancik Prize for Innovation in MS Research

Professor Katerina Akassoglou to receive 2018 Prize for work understanding the origins of nerve damage in MS and identifying potential therapies to stop it.
21-Jan-2019 3:05 PM EST Add to Favorites

Newswise: RhondaVoskuhl.jpg

Tailored Disability-Specific Neuroprotective Treatment Development in MS Offers a Potential New Approach

Dr. Rhonda Voskuhl professor at the University of California, Los Angeles, will present her hypothesis that molecular mechanisms underlying each disability may differ from each other based on regional differences in neurons, astrocytes and...
27-Nov-2018 4:55 PM EST Add to Favorites

Precision medicine approaches for multiple sclerosis will be featured at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2019 Forum

Fourth annual Forum will be held Feb. 28-March 2 in Dallas, Texas.
1-Nov-2018 12:05 PM EDT Add to Favorites


See All News

Our YouTube Videos

About

Founded in 1995, Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS®) is a community of leaders from the United States and Canada who are dedicated to the treatment and research in MS and other demyelinating diseases. ACTRIMS focuses on knowledge dissemination, education and collaboration among disciplines. ACTRIMS also provides an annual Forum for experienced and newer clinicians and researchers to exchange information, debate current issues and discuss advances related to basic research and clinical issues. One of the major initiatives of ACTRIMS is to foster the careers of young neurologists in training who have an interest in multiple sclerosis; this is done through a Resident Summit held in conjunction with the annual Forum and a standalone summit geared towards young scientists.

Experts

Contacts

Jennifer Brydges
Associate Director

jbrydges@actrims.org

608-310-8960

Twitter

close
0.31825